Effect of TEAS on Rocuronium Injection Pain

Pain from the injection of rocuronium is a common side effect during anesthetic practice, occurring in 50%-80% of patients. Several methods have been used to reduce this pain. This prospective, randomized study was designed to determine the efficacy of transcutaneous electrical acupuncture point stimulation in reducing the rocuronium injection pain.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Injection Pain

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Betul Kozanhan

Konya, 42005, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

18-65 year aged
ASA I-III
Who was to undergo various elective operations.

Exclusion criteria

Cardiovascular surgery
Patients with pacemakers
Patients requiring rapid sequential induction

Treatment and study plan

TEAS

Device

Transcutaneous electrical acupuncture stimulation

Primary outcomes

Pain with rocuronium injection

Time frame: 5 minutes

pain will be graded as no pain; mild pain; moderate pain; severe pain following administration of a priming dose of rocuronium

Sponsors and collaborators

Lead sponsor

Konya Meram State Hospital

Other

Registry information

Official study title

Efficacy of TEAS On Prevention of Rocuronium Injection Pain

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Jun 29, 2021
Registry last updated: Jan 6, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed